Clinical Trials for Human Epidermal Growth Factor 2 Negative Carcinoma of Breast

Find clinical trials for human epidermal growth factor 2 negative carcinoma of breast. Discover research opportunities and treatment options in your area.

6 Active Trials Found

Showing 6 trials on this page

Page 1 of 1

Assessing the Efficacy and Safety of Anti-HER2 Therapy in Nigerian Women With HER2+ Breast Cancer Before and After Surgery

NCT ID: NCT06348134

This clinical trial is designed to study how effective and safe a specific cancer treatment, called anti-HER2 therapy, is for Nigerian women with a type of breast cancer known as HER2-positive brea...

Not yet recruiting

Phase: PHASE2 Type: interventional Locations: Chicago, Illinois, United States, Ile Ife, Osun, Nigeria

Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer

NCT ID: NCT05735080

This clinical trial is studying a new oral medication called INX-315, which is being developed to treat advanced cancers, specifically hormone receptor-positive breast cancer and certain types of o...

Recruiting

Phase: PHASE1 Type: interventional Locations: Boston, Massachusetts, United States, Detroit, Michigan, United States +8 more

A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors

NCT ID: NCT06586957

This clinical trial is studying a new treatment called NKT3964 for adults with advanced or metastatic solid tumors, which are cancers that have spread beyond their original location. The trial aims...

Recruiting

Phase: PHASE1 Type: interventional Locations: Boston, Massachusetts, United States, Nashville, Tennessee, United States +6 more

Study of SHR-A1921 Combined Adebrelimab in HR-positive, HER2-negative Advanced Breast Cancer

NCT ID: NCT06470672

This clinical trial is studying a new treatment combination for women with advanced breast cancer that is hormone-receptor positive and HER2 negative. The treatment involves two drugs: SHR-A1921, w...

Not yet recruiting

Phase: PHASE2 Type: interventional Locations: Shanghai, Shanghai, China

Palbociclib in Metastatic Breast Cancer: Gene Polymorphism-based Study in Egyptian Patients.

NCT ID: NCT06338644

This clinical trial is studying a medication called Palbociclib for women with a specific type of advanced breast cancer known as hormone receptor-positive and HER2-negative metastatic breast cance...

Not yet recruiting

Type: observational

A Study to Evaluate the Efficacy and Safety of Oral Navelbine in Female Patients With HER2-Negative Metastatic Breast Cancer

NCT ID: NCT03854617

This clinical trial is studying the effectiveness and safety of a medication called oral Navelbine for women with a specific type of breast cancer known as HER2-negative metastatic breast cancer. T...

Not yet recruiting

Phase: PHASE2 Type: interventional

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions